Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

The Week Online with DRCNet, Issue #179

www.DRCNet.org

The Week Online with DRCNet, Issue #179

Friday 30 Mar 2001

---

The Week Online with DRCNet, Issue #179 -- March 30, 2001
A Publication of the Drug Reform Coordination Network

"Raising Awareness of the Consequences of Drug Prohibition"

Phillip S. Smith, Editor, psmith@drcnet.org
David Borden, Executive Director, borden@drcnet.org

Subscribe: http://www.drcnet.org/signup.html
Unsubscribe or change address: mailto:listhelp@drcnet.org
This issue on the web: http://www.drcnet.org/wol/179.html

7. DEA Denies Marijuana Rescheduling Petition -- Petitioners
Promise Appeal, Question Timing
http://www.drcnet.org/wol/179.html#gettman

For six years, the Drug Enforcement Administration had tried to
smother a formal petition to remove marijuana from its status as
a Schedule I drug under the Controlled Substances Act (CSA) --
one with high toxicity, high abuse potential, and no approved
medical use. But in a sudden burst of administrative activity,
conveniently preceding Wednesday's Supreme Court medical
marijuana oral arguments by less than a week, the agency last
week formally denied the petition submitted by Jon Gettman and
High Times magazine in July, 1995.

The novel administrative tactic, which would, for CSA purposes,
make marijuana roughly the equivalent of valium, could
potentially alter the drug war's terrain with a bureaucrat's
signature. After years of being ignored and stalled, Gettman and
High Times got the administrative equivalent of the bum's rush
from the DEA last week.

"They didn't even give us the opportunity for a hearing," Roberto
Rionda told DRCNet. Rionda, an attorney with the New York law
office of Michael Kennedy, which handled the case, added, "We
were informed by a seven-page letter, with 32 pages of Department
of Health and Human Services (HHS) findings to back up their
conclusions."

Rionda questioned the timing of the decision. "They wanted to
influence the Supreme Court, that's why they ruled now," he said.
The DEA's decision was a calculated effort to strengthen the
government's case with its reasoning in the denying the petition,
he said.

A press release from the Kennedy law office added that, "This
tactic poses a great danger to ill patients who rely on medical
marijuana because the Supreme Court's decision may be influenced
by the flawed conclusions of the DEA."

In denying the petition, the DEA found that marijuana has a high
abuse potential -- similar to heroin or cocaine -- and that even
if it did not have a high toxicity or abuse potential, it had no
accepted medical use and must therefore remain in Schedule I.

Confronted with plentiful evidence of marijuana's relatively low
dependency levels and practically nonexistent toxicity, the
agency grew expansive in defining the plant's substance abuse
potential. Arguing that other factors, such as "failure to
fulfill major obligations at work or school, physical risk-
taking, or even substance-related legal problems, are indicative
of a substance's abuse potential, the agency attempted to make
the case that marijuana's potential for abuse merited its
inclusion in the same category as heroin, methamphetamine, and
ecstasy.

Among the DEA's indicators of high abuse potential was broad use,
which, when combined with the DEA's official position that any
use of an illegal drug constitutes "drug abuse," leads to the
Kafkaesque tautology that because marijuana use is illegal it
constitutes abuse, and because it is therefore widely abused it
must remain illegal.

Again departing from consensus reality, the DEA continued to
maintain that marijuana had no approved medical uses. It ignored
the fact that eight states have embraced marijuana as medicine at
the ballot box, and it ignored the government-sponsored Institute
of Medicine study that charted marijuana's medical uses.

Gettman, High Times, and their lawyers aren't buying that logic,
nor are they giving up the fight. "We have 30 days to appeal to
the US District of Columbia Circuit Court, and we will absolutely
file before that deadline," Rionda told DRCNet.



 

 

 

After you have finished reading this article you can click here to go back.




This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!